Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-27

FDA Approved: LAMPIT — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lampit (nifurtimox) from Bayer HealthCare Pharmaceuticals Inc., expanding the drug's approved indications. The actio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lampit (nifurtimox)

Snippet

SUPPL AP for LAMPIT (NIFURTIMOX)